Artiva Biotherapeutics
ARTV
#9030
Rank
HK$0.99 B
Marketcap
HK$40.38
Share price
57.63%
Change (1 day)
-50.07%
Change (1 year)

Revenue for Artiva Biotherapeutics (ARTV)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of HK$1.94 Million a decrease over the revenue in the year 2023 that were of HK$0.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Artiva Biotherapeutics from 2023 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A-100%
2024 HK$1.94 M-99.17%
2023 HK$0.23 B